GABY Inc. is a publicly traded cannabis company, listed on the CSE and OTCQB. By the end of 2022, the company plans to expand to additional retail locations, eventually becoming a dominant player in the California market.
The company’s flagship Mankind Dispensary serves nearly 30,000 shoppers per month, has a robust delivery and curbside pickup program, and stocks more than 700 unique products at any time, including GABY’s Kind Republic flower, prerolls, and extracts.
GABY’s leadership team of retail and cannabis experts curate industry-leading experiences which celebrate cannabis culture, and introduces customers to some of the best cannabis in the world.
By operating an expanding portfolio of brands and dispensaries, GABY is building a consumer-focused ecosystem that keeps shoppers happy, prices accessible, and builds lifelong connections between brands and their consumers.
GABY Inc. (GABY)
le 6 septembre/September 2023
Effective immediately, GABY inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commissions.
For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca